Neurocrine Biosciences NBIX Business Segments — Provision for income taxes
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neurocrine Biosciences's business segments — provision for income taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neurocrine Biosciences's business segments — provision for income taxes?
- Neurocrine Biosciences (NBIX) reported business segments — provision for income taxes of $48.9M in Q1 2026.
- How has Neurocrine Biosciences's business segments — provision for income taxes changed year-over-year?
- Neurocrine Biosciences's business segments — provision for income taxes increased by 619.1% year-over-year, from $6.8M to $48.9M.
- What is the long-term trend for Neurocrine Biosciences's business segments — provision for income taxes?
- Over 3 years (2022 to 2025), Neurocrine Biosciences's business segments — provision for income taxes has grown at a 56.3% compound annual growth rate (CAGR), from $59.4M to $226.8M.
- What does business segments — provision for income taxes mean?
- The estimated tax expense calculated on the company's pre-tax earnings based on applicable tax laws. This reflects the company's effective tax rate and regulatory obligations.